Plum SEC
Menu
Korean Market
Privacy Policy
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
EXCH
Vaxcell-Bio Therapeutics
★
Investor Relations Meeting
05/18/2026, 04:56 PM
PERI
Vaxcell-Bio Therapeutics
★
VaxCell-Bio Q1 2026: Revenue 1.54B Won, Operating Loss 4.62B Won; Pipeline Progress and Distribution Business Stabilization
05/15/2026, 05:02 PM